title: Outcome of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli: impact of microbiological determinants.
abstract: OBJECTIVE
  To investigate the impact of virulence factors (VF) and other microbiological determinants on the outcome of patients with invasive infections due to extended-spectrum β-lactamase-producing Escherichia coli (ESBLEC).
  
  
  METHODS
  A prospective multicentre cohort including 191 patients with bacteraemia due to ESBLEC from 13 hospitals in Spain was studied. Phylogroups and 25 genes encoding for putative VF were studied by PCR. Main outcome variable was 30-day mortality; presentation with severe sepsis or septic shock was also assessed. Logistic regression was used to performed multivariate analyses.
  
  
  RESULTS
  After controlling for patient comorbidity, source, and empirical antimicrobial therapy, ibeA (OR = 3.41; 95% CI: 0.96-12.10) and amoxicillin-clavulanate resistance (OR = 2.38; 95% CI: 1.07-5.26) were independently associated with increased mortality, while papGII showed a protective effect (OR = 0.18; 95% CI: 0.04-0.87). When these 3 variables were deleted from the multivariate model, the area under the ROC curve decreased only from 0.83 to 0.77. papGII also showed a protective effect for presentation with severe sepsis or septic shock (adjusted OR = 0.34; 95% CI: 0.10-1.14).
  
  
  CONCLUSIONS
  Some pathogen-associated determinants showed a significant although limited impact on outcome in bacteraemic infections due to ESBLEC, and should be further studied as potential therapeutic or preventive targets.
authors.affiliation: Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Avda Dr. Fedriani 3, Seville, Spain. jesusrb@us.es
authors.forename: Jesús
authors.initials: J
authors.lastname: Rodríguez-Baño
authors.forename: Jesús
authors.initials: J
authors.lastname: Mingorance
authors.forename: Natalia
authors.initials: N
authors.lastname: Fernández-Romero
authors.forename: Lara
authors.initials: L
authors.lastname: Serrano
authors.forename: Lorena
authors.initials: L
authors.lastname: López-Cerero
authors.forename: Alvaro
authors.initials: A
authors.lastname: Pascual
mesh_terms: D000368:Aged; D016470:Bacteremia / Q000188:drug therapy* / Q000401:mortality*; D004926:Escherichia coli / Q000201:enzymology* / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000401:mortality*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D013030:Spain; D016019:Survival Analysis; D016896:Treatment Outcome; D037521:Virulence Factors / Q000235:genetics; D001618:beta-Lactamases / Q000378:metabolism*
chemical_list: D037521:Virulence Factors; D001618:beta-Lactamases